The Board of Maven Income and Growth VCT 3 PLC (the Company) confirms that, on 16 April 2021 and under its Dividend Investment Scheme (DIS), the Company issued and allotted 156,034 new ordinary shares of 10p each (Ordinary Shares) at a price of 57.25p per share which, under the Terms and Conditions of the DIS, is equivalent to the latest announced net asset value per share . As a result, and in accordance with the Financial Conduct Authority s Disclosure, Guidance and Transparency Rules, the Company confirms that its issued share capital as at 16 April 2021 comprises 79,259,613 Ordinary Shares, with each share carrying one voting right. The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required, under the Disclosure, Guidance and Transparency Rules, to notify their interest, or a change to thei
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
The year to 30 November 2020 has been one of considerable challenge, dominated by the outbreak of COVID-19, which has had an unparalleled impact on the economy and our society. Our thoughts are with all those who have been affected by the crisis.
Despite the wide-reaching disruption caused by the pandemic, it is encouraging to report that your Company has generated a modest uplift in NAV total return at the year end to 144.44p per share. This reflects a significant recovery following the revaluation of the portfolio that was announced on 26 March 2020, when a small number of specific provisions were taken against those companies that were most immediately impacted by the economic disruption caused by the pandemic. Notwithstanding the market conditions, this has been a year of progress during which £10.5 million has been invested across a range of carefully selected new private and AIM quoted companies, alongside the provision of follow-on funding to support the continuing g